Luxembourg stands out as the European leader in quality of life for 2025, achieving a score of 220 on the Quality of Life Index. The Netherlands follows closely behind with 211 points, while Albania and Ukraine rank at the bottom with scores of 104 and 115 respectively. This index provides a thorough assessment of living conditions across Europe, reflecting various factors that shape the overall well-being of populations and extending beyond purely economic metrics. Understanding the quality of life index The quality of life index is a multifaceted measure that incorporates factors such as purchasing power, pollution levels, housing affordability, cost of living, safety, healthcare quality, traffic conditions, and climate, to measure the overall quality of life of a Country. Higher overall index scores indicate better living conditions. However, in subindexes such as pollution, cost of living, and traffic commute time, lower values correspond to improved quality of life. Challenges affecting life satisfaction Despite the fact that European countries register high levels of life quality by for example leading the ranking of happiest countries in the world, life satisfaction across the European Union has been on a downward trend since 2018. The EU's overall life satisfaction score dropped from 7.3 out of 10 in 2018 to 7.1 in 2022. This decline can be attributed to various factors, including the COVID-19 pandemic and economic challenges such as high inflation. Rising housing costs, in particular, have emerged as a critical concern, significantly affecting quality of life. This issue has played a central role in shaping voter priorities for the European Parliamentary Elections in 2024 and becoming one of the most pressing challenges for Europeans, profoundly influencing both daily experiences and long-term well-being.

Many studies have shown that childhood circumstances can have long term consequences that persist until old age. To better understand the transmission of early life circumstances, this paper analyses the effects of health and financial situation during childhood on quality of life after retirement as well as the mediating role of later life health, educational level, and income in this association. Moreover, this study is the first to compare these pathways across European regions. The analyses are based on data of 13,092 retirees aged ≥ 60 and ≤ 85 years from the fifth wave of the Survey of Health, Aging, and Retirement in Europe (SHARE) with full information on childhood and later life measures of health, educational level, financial situation, and quality of life as well as relevant covariates. Five European regions are studied: Central-Western Europe (Austria, Germany), Central-Eastern Europe (Czech Republic, Estonia, Slovenia), Northern Europe (Denmark, Sweden), Southern Europe (Italy, Spain), and Western Europe (Belgium, France, The Netherlands). Path analysis is used to identify the direct and indirect effects of childhood measures on quality of life. We find retirees’ quality of life to be associated with childhood finances and health in all five European regions. While both the direct and indirect effects of childhood health are rather moderate and homogeneous across regions, especially the direct effects of childhood finances on quality of life after retirement display a distinct North-South gradient being strongest in Southern Europe. Potential explanations for the regional variations are differences in the countries’ welfare systems.

The GLA undertake regular polling of Londoners views both online and by telephone. A representative sample is interviewed, with quotas set by age, gender and borough. The results from these polls appear on this page.

April 2009 - Economic outlook, and the Mayor's role

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

June 2009 - Quality of life

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

November 2009 - Waste and recycling

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

March 2010 - Culture

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

May 2010 - Climate Change

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

August 2010 - Energy, and Safety in Parks

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

December 2010 - Mayoral Priorities

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

March 2011 - Volunteering

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

June 2011 - Housing, economy, sport, 2012 games

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

September 2011 - Community cohesion and festivals

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

November 2011 - Economy, community cohesion, young people, sports

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

February 2012 - Economy and volunteering

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

June 2012 - Economy and Londoners priorities

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

October 2012 - Economy, Mayoral responsibilities and 2012 Games

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

January 2013 - Economy, apprenticeships, aiport, housing and EU

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

March 2013 – Economy, volunteering, ULEZ, stamp duty, cycling

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

June 2013 - Economy, culture and community cohesion

Link to PDF of toplines (PDF)

Link to PDF tables (PDF)

September 2013 - Economy, Mayoral responsibilities

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

November 2013 - Economy, cost of living, technology and aiports

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

February 2014 - Water Cannon

Link to Data Full Tables (XLS)

Tables – rebased (XLS)

Tables - ethnicity (XLS)

Tables - summary (XLS)

February 2014 - Economy, cost of living, priorities and culture

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

March 2014 - Health Survey

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

May 2014 - Priorities for Safety

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

June 2014 - Economy, cost of living, personal finance, housing and airports

Link to PDF of toplines (PDF)

August 2014 - Health Survey

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

September 2014 - Awareness, sources, carrier bags and big dance

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

January 2015 – Economy, cost of living, living wage, affordable eating, cooking fats, physical activity major events

Link to PDF of toplines (PDF)

Link to Excel tables (XLS)

March 2015 - Growth, recycling and reuse

Link to PDF of toplines (PDF)

<a

A Eurobarometer survey published today on the 4th World Rare Disease Day reveals that Europeans have a relatively accurate understanding of what rare diseases are but detailed knowledge and awareness remain low. The European public expresses strong support for policy initiatives linked to rare diseases at both national and European level, and Europeans see the actions of allocating resources to improve research, ensuring access to care and raising awareness as highly justified. However, significant disparities between Member States remain. The European Commission promotes joint actions which will help patients and professionals share expertise and information across borders with the objective of reducing the number of people suffering these type of diseases, preventing newborns and young children dying from them and improving the patients’ quality of life. Specific measures have been adopted by the Commission, including: - improving recognition and visibility of rare diseases; - supporting national plans for rare diseases in EU member countries; - strengthening European-level cooperation and coordination; - creating European reference networks, linking centres of expertise and professionals in different countries to share knowledge and identify where patients should go when expertise is unavailable in their home country; - encouraging more research into rare diseases. #####The results by volumes are distributed as follows: * Volume A: Countries * Volume AA: Groups of countries * Volume A' (AP): Trends * Volume AA' (AAP): Trends of groups of countries * Volume B: EU/socio-demographics * Volume C: Country/socio-demographics ---- Researchers may also contact GESIS - Leibniz Institute for the Social Sciences: http://www.gesis.org/en/home/

This round of Eurobarometer surveys queried respondents on standard Eurobarometer measures such as public awareness of and attitudes toward the European Union (EU), and also focused on applications of modern biotechnology, quality of life and lifestyle, the EC symbol, and consumers' access to justice. Respondents were asked whether they believed that new, developing technologies such as biotechnology and genetic engineering, computers and information technology, telecommunications, the Internet, new materials and substances, solar energy, space exploration, and nuclear energy would improve their lives over the next 20 years. They were also prompted for what came to mind when they thought of modern biotechnology, and if they had a positive or negative opinion about specific areas of biotechnology such as the cloning of animals or humans, health research, and genetically engineered food. Those queried were asked to indicate whether a number of statements having to do with modern biotechnology were true or false, including "There are bacteria that live in waste water" and "Yeast for brewing beer consists of living organisms." They were also asked to agree or disagree that various applications of modern biotechnology are useful, a risk for society, morally acceptable, or should be encouraged. Agreement/disagreement was also sought on a number of statements, such as "Cloning animals will bring benefits to a lot of people," "Genetically modified food will bring benefits to a lot of people," "I would buy genetically modified fruits if they tasted better," and "I feel sufficiently informed about biotechnology." Respondents were asked if they felt that the various entities involved in modern technology (i.e., newspapers and magazines, the biotechnology industry, ethics committees, consumer organizations, environmental groups, the government, shops, farmers, churches, and doctors) were doing a good job for society and which sources, if any, they could trust to tell the truth about modern biotechnology. Regarding quality of life, respondents were asked about their satisfaction with life in general, their health, the health care system, family life, social life, personal safety, their financial situation, employment situation, home, and neighborhood. They were asked how their current satisfaction in these areas compared to two years ago and if they thought they would be more or less satisfied in these areas two years from now. From a list of 15 choices, respondents were asked to select three factors that contributed most to their current quality of life and three that would most improve it. Given a list of places people might visit (e.g., work, a health center, the hospital, the supermarket, etc.), respondents were asked how long it would take to get there and to which places they would walk. Other questions queried respondents about their current standard of living and monthly income, whether they had a healthy lifestyle, had a good diet, exercised, drank alcohol, smoked, or were stressed, whether in the last 12 months they had consulted a family doctor, a dentist, or a medical specialist, whether they had been a patient in a hospital or clinic for overnight or longer, and if they had any long-standing illness, disability, or infirmity that limited their activities. They were also asked what types of leisure activities they participated in and which they would do, or do more of, if they had more time. In addition, respondents were asked if the Internet, personal computers, or mobile phones were positive or negative in terms of their quality of life, if the government should spend more to ensure everyone access to these new technologies, and if respondents had participated in training activities related to these new technologies. Several questions about the poor and the socially excluded asked if respondents had given money, goods, or their time to help these groups and if, in their opinion, housing authorities, employment services, social services, religious institutions, charities, businesses, trade unions, their family, the European Union, or the poor themselves currently provided the most help. Another series of questions asked respondents about the EC symbol -- its meaning, who put it on products, on which items they had seen the symbol, and how often they took the symbol into account when they bought products. They were asked how well informed they felt as consumers, in what form they would like to get information on their rights as a consumer (i.e., an outline, a detailed booklet, a complete description, a videotape, etc.), if they had ever had to complain about a purchase, whom they complained to or would complain to, and whether they complained or would complain in person, by phone, in writing, by e-mail, or in some other fashion. They were asked if they had heard of bodies such as arbitrators, counselors, ombudsmen, etc., that deal with consumer disputes and if they would be willing to bring their problem before one of these agents or if they had fears about them. Further questions queried respondents about whether in the last five years they had had a problem that they could not get resolved, what type of product or service was involved, and what they did when they could not resolve the problem. They were questioned as to the minimum amount it would take to bring the problem to court, why they would not bring it to court for less, whether they had insurance that would cover the legal costs, if they would be more likely to go to court if they joined other consumers with the same problem, what would most encourage them to defend their rights in court, in whom they had the most confidence to defend consumers in court, how much confidence they had in the courts to settle disputes, and who could best protect consumer interests. Similar questions were asked concerning products bought abroad -- the amount it would take to bring the dispute to court, if they had ever had a problem with a product or service bought abroad, if they did anything about the problem, how satisfied they were with the results, and if it would be useful to have one form that could be used throughout the European Union to complain about a product or service problem. Information was also collected on whether anyone in the household owned a color TV, a video recorder, a video camera, a clock radio, a home computer, a still camera, an electric drill, an electric deep-fat fryer, two or more cars, or a second or holiday home. Standard demographic information collected included age, sex, nationality, left-right political self-placement, marital status, age at completion of education, number of people in household, number of children in household, current occupation, previous occupation, religiosity, household income, type of residence, size of locality,region of residence, and nationality. (Source: downloaded from ICPSR 7/13/10)

Please Note: This dataset is part of the historical CISER Data Archive Collection and is also available at ICPSR -- https://doi.org/10.3886/ICPSR02893.v4. We highly recommend using the ICPSR version as they made this dataset available in multiple data formats.

The European Clinical Data Analytics market in healthcare is experiencing robust growth, projected to reach €6.13 billion in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 29.87% from 2025 to 2033. This expansion is fueled by several key drivers. Increasing adoption of Electronic Health Records (EHRs) across European healthcare systems provides a rich data source for analytics. Furthermore, the rising prevalence of chronic diseases necessitates improved patient care management, which is significantly enhanced by data-driven insights. Stringent regulatory compliance mandates, such as GDPR, although posing initial challenges, ultimately drive investment in robust and secure data analytics solutions. The market's segmentation reveals strong demand across deployment models (on-premise and cloud), with cloud-based solutions gaining traction due to scalability and cost-effectiveness. Application-wise, clinical data analytics holds a significant share, followed by financial and operational/administrative analytics, reflecting the broad applicability of these tools. The payer and provider segments are major end-users, emphasizing the importance of data analytics across the healthcare value chain. Key players such as SAS Institute, IQVIA, IBM, and McKesson are actively shaping the market landscape through technological innovations and strategic partnerships. Geographic concentration within Europe shows strong performance from major economies such as the United Kingdom, Germany, and France, driven by advanced healthcare infrastructure and substantial government investments in digital health initiatives. The continued growth trajectory of the European Clinical Data Analytics market is anticipated to be driven by several factors in the coming years. Advances in artificial intelligence (AI) and machine learning (ML) are leading to the development of sophisticated predictive models for disease management, risk stratification, and personalized medicine. The increasing adoption of telehealth and remote patient monitoring further generates substantial volumes of data demanding robust analytical capabilities. Investment in data infrastructure and cybersecurity is crucial to ensure data integrity and privacy, representing a significant opportunity for market players. However, challenges remain. Data interoperability issues across diverse healthcare systems continue to hinder seamless data integration and analysis. Furthermore, the shortage of skilled professionals with expertise in data science and healthcare analytics represents a bottleneck to realizing the full potential of this technology. Despite these hurdles, the long-term outlook for the European Clinical Data Analytics market remains highly positive, driven by the sustained focus on improving healthcare efficiency, quality, and patient outcomes. Europe Clinical Data Analytics Market In Healthcare: A Comprehensive Report (2019-2033) This comprehensive report provides a detailed analysis of the European clinical data analytics market in healthcare, offering invaluable insights for stakeholders across the industry. Using data from 2019-2024 (historical period), a base year of 2025, and projecting to 2033 (forecast period), this report covers market size, growth drivers, challenges, and emerging trends. Key players like SAS Institute Inc, IQVIA Inc, and IBM Corporation are analyzed, and the report also segments the market by deployment (on-premise, cloud), application (clinical, financial, operational/administrative data analytics), and end-user (payers, providers). Recent developments include: July 2023, Pure Storage, the IT pioneer that delivers the most advanced data storage technology and services, announced that the University Hospital Center of Saint-Etienne, one of the leading university hospitals in Southeast France, is leveraging its portfolio - including Pure1, FlashArray, and its Evergreen architecture to accelerate and secure access to critical data to improve overall patient care and business continuity., June 2023: Flatiron Health, a leading health tech company, collaborated with the Leeds Teaching Hospitals NHS Trust (LTHT), one of Europe's largest acute hospital trusts. In the United Kingdom, the agreement signals a new phase for Flatiron Health to advance research and improve care, treatment and quality of life for patients around the world.. Key drivers for this market are: Reduced Cost of Care and Prediction of Possible Emergency Services, Increasing Evidence-based Activities and Shift from Volume to Value-based Commissioning. Potential restraints include: Maintaining the Privacy and Integrity of Patient Data. Notable trends are: Cloud to Witness Significant Growth.

Data on European cities were collected in the Urban Audit and in the Large City Audit project. The projects' ultimate goal is to contribute towards the improvement of the quality of urban life: it supports the exchange of experience among European cities; it helps to identify best practices; it facilitates benchmarking at the European level and provides information on the dynamics within the cities and with their surroundings.

At the city level, the Urban Audit contains more than 130 variables and more than 50 indicators. These indicators are derived from the variables collected by the European Statistical System.

The data is published in 20 tables within 2 main groups, plus a perception survey table:

Cities and greater cities (urb_cgc)

Population on 1 January by age groups and sex - cities and greater cities (urb_cpop1)
Population structure - cities and greater cities (urb_cpopstr)
Population by citizenship and country of birth - cities and greater cities (urb_cpopcb)
Fertility and mortality - cities and greater cities (urb_cfermor)

Living conditions - cities and greater cities (urb_clivcon)

Education - cities and greater cities (urb_ceduc)

Culture and tourism - cities and greater cities (urb_ctour)
Labour market - cities and greater cities (urb_clma)
Economy and finance - cities and greater cities (urb_cecfi)
Transport - cities and greater cities (urb_ctran)
Environment - cities and greater cities (urb_cenv)

Functional Urban Area (urb_luz)

Population on 1 January by age groups and sex - Functional Urban Area (urb_lpop1)
Population structure - Functional Urban Area (urb_lpopstr)
Population by citizenship and country of birth - Functional Urban Area (urb_lpopcb)
Fertility and mortality - Functional Urban Area (urb_lfermor)
Living conditions - Functional Urban Area (urb_llivcon)
Education - Functional Urban Area (urb_leduc)
Labour market - Functional Urban Area (urb_llma)
Transport - Functional Urban Area (urb_ltran)
Environment - Functional Urban Area (urb_lenv)
Perception survey results (urb_percep)

Data has been collected on two spatial levels in the Urban Audit:

• The City (C) according to the administrative definition, as the basic level,
• The Functional Urban Area (FUA) being an approximation of the functional urban zone centered around the city

In 2023, Norway ranked first with a health index score of 83, followed by Iceland and Sweden. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The statistic shows the health and health systems ranking of European countries in 2023, by their health index score.

BackgroundThe comorbidities associated with overweight and obesity have been well researched and scientifically proven while their relationship to mental health is still not verified.MethodsThis study is aimed at investigating reciprocal associations between obesity and mental health, and is intended to further analyze possible long-term effects using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). In order to do that, waves 4 and 8, conducted in 2010 and 2019/20 of this survey, were analyzed in a cross-lagged panel approach including 16,184 adult Europeans (50+) using multiple linear regression analysis focusing on the Body Mass Index (BMI), depression status and quality of life (QoL).ResultsFindings yield significant cross-lagged effects in one direction regarding BMI predicting QoL and depression state, whereas depression state and QoL do not significantly predict BMI. Findings include people living with obesity, overweight, and underweight showing significantly decreased levels of QoL as well as increased depression scores compared to people of normal weight over a lag time of 10 years, where people living with obesity indicate the strongest effect.ConclusionsHowever, results do not confirm reciprocal associations in the long term. Hence, there is a strong need to carry out further research on this issue.

The cities in Europe where survey respondents most commonly indicated that they were a good place to live for gay and lesbian people were Rekjavik,Valletta and Groningen in 2023. In general, the cities which ranked as the best place to live for lesbian and gay people in Europe were in Nordic countries (Norway, Iceland, Copenhagen, Sweden, Finland), western European countries (Luxembourg, Germany, the Netherlands), and southern European countries (Italy, Malta, Spain). The five cities with the fewest respondents indicating that they were a good place to live were all in south-eastern Europe, with the bottom two both coming from Turkey (Diyarbakir) and Albania (Tirania). Turkey tends to rank so lowly due to the influence of traditionalist and religious social norms, which do not recognize LGBTQ relationships as being on a par as heterosexual relationships and lead to more commonly held homophobic views.

Home Healthcare Product and Service Market Outlook

The global home healthcare product and service market size was valued at USD 205 billion in 2023 and is expected to reach approximately USD 450 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.4%. This growth can be attributed to an aging global population, increasing prevalence of chronic diseases, and technological advancements in healthcare. The rising preference for receiving healthcare services within the comfort of home is driving the market's expansion, making it a vital segment of the healthcare industry.

One of the primary growth factors propelling the home healthcare market is the aging population worldwide. As the elderly population increases, there is a corresponding rise in the need for healthcare services that can be administered at home. This demographic shift is particularly noticeable in regions such as North America, Europe, and parts of Asia, where the proportion of elderly individuals is growing rapidly. Home healthcare services and products cater to the specific needs of this segment, providing convenience, comfort, and often cost savings compared to traditional in-hospital care.

Another significant growth driver is the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders. These conditions often require ongoing management, continuous monitoring, and frequent medical interventions, which can be effectively managed through home healthcare solutions. The ability to monitor and treat patients in their homes not only improves their quality of life but also reduces the burden on healthcare facilities and systems. Furthermore, technological advancements like remote patient monitoring devices, wearable health technology, and telemedicine services enhance the efficiency and effectiveness of home healthcare, contributing to market growth.

The rise in healthcare costs is also pushing patients and healthcare providers toward home healthcare services. Hospital stays and traditional healthcare services are becoming increasingly expensive, and home healthcare offers a cost-effective alternative without compromising the quality of care. Insurance providers are also recognizing the benefits and cost savings associated with home healthcare, leading to better coverage and reimbursement policies for these services. This financial incentive is a crucial factor in the market's expansion, encouraging more patients and providers to adopt home healthcare solutions.

Regionally, North America holds a significant share of the home healthcare market, driven by the high adoption of advanced healthcare technologies, a well-established healthcare infrastructure, and favorable government policies. Europe follows closely, with a strong focus on providing high-quality home healthcare services to its aging population. The Asia Pacific region is expected to witness the highest growth during the forecast period due to increasing healthcare awareness, rising disposable incomes, and a growing elderly population. Latin America and the Middle East & Africa are also showing promising growth, albeit at a slower rate compared to other regions.

Product Type Analysis

The home healthcare market by product type includes therapeutic products, diagnostic products, mobility assist products, and others. Therapeutic products, such as insulin delivery devices, home dialysis equipment, and respiratory therapy devices, are experiencing high demand due to the increasing prevalence of chronic diseases and the need for ongoing medical care at home. These products enable patients to manage their conditions effectively without frequent hospital visits, thus improving their quality of life and reducing healthcare costs.

Diagnostic products, including blood glucose monitors, blood pressure monitors, and home pregnancy tests, are another crucial segment of the home healthcare market. These products empower patients to conduct essential health checks and monitor their health status regularly from the comfort of their homes. The increasing awareness about the importance of early diagnosis and regular health monitoring is driving the demand for these diagnostic products. Moreover, technological advancements are making these products more user-friendly and accurate, further boosting their adoption.

Mobility assist products, such as wheelchairs, walkers, and mobility scooters, cater to the needs of individuals with mobility impairments, including the elderly and disabled population. These products play a critical role in enhancin

83% of EU respondents say that the quality of life in their region is good (+3% since 2018), while 68% say that the situation of the economy of their region is good (+2% since 2018). 71% say they are optimistic regarding the future of their region (+3% since 2018).

Processed data

Processed data files for the Eurobarometer surveys are published in .xlsx format.

• Volume A "Countries/EU" The file contains frequencies and means or other synthetic indicators including elementary bivariate statistics describing distribution patterns of (weighted) replies for each country or territory and for (weighted) EU results.
• Volume AP "Trends" The file compares to previous poll in (weighted) frequencies and means (or other synthetic indicators including elementary bivariate statistics describing distribution patterns of replies); shifts for each country or territory foreseen in Volume A and for (weighted) results.
• Volume AA "Groups of countries" The file contains (labelled) frequencies and means or other synthetic indicators including elementary bivariate statistics describing distribution patterns of (weighted) replies for groups of countries specified by the managing unit on the part of the EC.
• Volume AAP "Trends of groups of countries" The file contains shifts compared to the previous poll in (weighted) frequencies and means (or other synthetic indicators including elementary bivariate statistics describing distribution patterns of replies); shifts for each groups of countries foreseen in Volume AA and for (weighted) results.
• Volume B "EU/socio-demographics" The file contains (labelled) frequencies and means or other synthetic indicators including elementary bivariate statistics describing distribution patterns of replies for the EU as a whole (weighted) and cross-tabulated by some 20 sociodemographic, socio-political or other variables, depending on the request from the managing unit on the part of the EC or the managing department of the other contracting authorities.
• Volume BP "Trends of EU/socio-demographics" The file contains shifts compared to the previous poll in (weighted) frequencies and means (or other synthetic indicators including elementary bivariate statistics describing distribution patterns of replies); shifts for each country or territory foreseen in Volume B above)and for (weighted) results.
• Volume C "Country/socio-demographics" The file contains (labelled) weighted frequencies and means or other synthetic indicators including elementary bivariate statistics describing distribution patterns of replies for each country or territory surveyed separately and cross-tabulated by some 20 socio-demographic, socio-political or other variables (including a regional breakdown).

For SPSS files and questionnaires, please contact GESIS - Leibniz Institute for the Social Sciences: https://www.gesis.org/eurobarometer

Data on European cities were collected in the Urban Audit and in the Large City Audit project. The projects' ultimate goal is to contribute towards the improvement of the quality of urban life: it supports the exchange of experience among European cities; it helps to identify best practices; it facilitates benchmarking at the European level and provides information on the dynamics within the cities and with their surroundings.

At the city level, the Urban Audit contains more than 130 variables and more than 50 indicators. These indicators are derived from the variables collected by the European Statistical System.

The data is published in 20 tables within 2 main groups, plus a perception survey table:

Cities and greater cities (urb_cgc)

Population on 1 January by age groups and sex - cities and greater cities (urb_cpop1)
Population structure - cities and greater cities (urb_cpopstr)
Population by citizenship and country of birth - cities and greater cities (urb_cpopcb)
Fertility and mortality - cities and greater cities (urb_cfermor)

Living conditions - cities and greater cities (urb_clivcon)

Education - cities and greater cities (urb_ceduc)

Culture and tourism - cities and greater cities (urb_ctour)
Labour market - cities and greater cities (urb_clma)
Economy and finance - cities and greater cities (urb_cecfi)
Transport - cities and greater cities (urb_ctran)
Environment - cities and greater cities (urb_cenv)

Functional Urban Area (urb_luz)

Population on 1 January by age groups and sex - Functional Urban Area (urb_lpop1)
Population structure - Functional Urban Area (urb_lpopstr)
Population by citizenship and country of birth - Functional Urban Area (urb_lpopcb)
Fertility and mortality - Functional Urban Area (urb_lfermor)
Living conditions - Functional Urban Area (urb_llivcon)
Education - Functional Urban Area (urb_leduc)
Labour market - Functional Urban Area (urb_llma)
Transport - Functional Urban Area (urb_ltran)
Environment - Functional Urban Area (urb_lenv)
Perception survey results (urb_percep)

Data has been collected on two spatial levels in the Urban Audit:

• The City (C) according to the administrative definition, as the basic level,
• The Functional Urban Area (FUA) being an approximation of the functional urban zone centered around the city

BackgroundEstimating the burden of healthcare-associated infections (HAIs) compared to other communicable diseases is an ongoing challenge given the need for good quality data on the incidence of these infections and the involved comorbidities. Based on the methodology of the Burden of Communicable Diseases in Europe (BCoDE) project and 2011–2012 data from the European Centre for Disease Prevention and Control (ECDC) point prevalence survey (PPS) of HAIs and antimicrobial use in European acute care hospitals, we estimated the burden of six common HAIs.Methods and FindingsThe included HAIs were healthcare-associated pneumonia (HAP), healthcare-associated urinary tract infection (HA UTI), surgical site infection (SSI), healthcare-associated Clostridium difficile infection (HA CDI), healthcare-associated neonatal sepsis, and healthcare-associated primary bloodstream infection (HA primary BSI). The burden of these HAIs was measured in disability-adjusted life years (DALYs). Evidence relating to the disease progression pathway of each type of HAI was collected through systematic literature reviews, in order to estimate the risks attributable to HAIs. For each of the six HAIs, gender and age group prevalence from the ECDC PPS was converted into incidence rates by applying the Rhame and Sudderth formula. We adjusted for reduced life expectancy within the hospital population using three severity groups based on McCabe score data from the ECDC PPS. We estimated that 2,609,911 new cases of HAI occur every year in the European Union and European Economic Area (EU/EEA). The cumulative burden of the six HAIs was estimated at 501 DALYs per 100,000 general population each year in EU/EEA. HAP and HA primary BSI were associated with the highest burden and represented more than 60% of the total burden, with 169 and 145 DALYs per 100,000 total population, respectively. HA UTI, SSI, HA CDI, and HA primary BSI ranked as the third to sixth syndromes in terms of burden of disease. HAP and HA primary BSI were associated with the highest burden because of their high severity. The cumulative burden of the six HAIs was higher than the total burden of all other 32 communicable diseases included in the BCoDE 2009–2013 study. The main limitations of the study are the variability in the parameter estimates, in particular the disease models’ case fatalities, and the use of the Rhame and Sudderth formula for estimating incident number of cases from prevalence data.ConclusionsWe estimated the EU/EEA burden of HAIs in DALYs in 2011–2012 using a transparent and evidence-based approach that allows for combining estimates of morbidity and of mortality in order to compare with other diseases and to inform a comprehensive ranking suitable for prioritization. Our results highlight the high burden of HAIs and the need for increased efforts for their prevention and control. Furthermore, our model should allow for estimations of the potential benefit of preventive measures on the burden of HAIs in the EU/EEA.

Pet Veterinary Supplements Market Outlook

As of 2023, the global pet veterinary supplements market size is estimated to be valued at approximately USD 3.5 billion, and it is poised to reach an impressive USD 6.8 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 7.8% over the forecast period. The market's growth is primarily driven by the increasing pet ownership rates globally, coupled with a growing awareness among pet owners regarding the health and well-being of their pets.

One of the major growth factors propelling the pet veterinary supplements market is the rising trend of pet humanization, where pets are increasingly being treated as family members. This shift in perception has led pet owners to seek high-quality supplements to enhance their pets' health and longevity. Additionally, advancements in veterinary science and nutrition have resulted in the development of more effective and specialized supplements, further boosting market growth. Furthermore, increasing disposable incomes and the willingness of pet owners to spend on premium products for their pets are contributing significantly to the market expansion.

Another critical growth factor is the increasing prevalence of chronic diseases and health issues in pets, such as arthritis, obesity, and digestive disorders. This has heightened the demand for veterinary supplements that can help manage or prevent these conditions. For instance, joint health supplements are becoming increasingly popular among aging pet populations to support mobility and alleviate pain. Similarly, digestive health supplements are in demand to address gastrointestinal issues, improving the overall quality of life for pets. The growing focus on preventive healthcare and wellness for pets is also driving the adoption of veterinary supplements.

The expanding distribution network for pet veterinary supplements is also a significant contributor to market growth. The availability of these products has increased not only in traditional veterinary clinics and pet stores but also through online platforms, making it easier for pet owners to access a wide range of supplements. E-commerce platforms, in particular, have seen significant growth, offering convenience and a broader selection of products. Additionally, collaborations between supplement manufacturers and veterinary professionals are helping to raise awareness and educate pet owners about the benefits of using veterinary supplements.

Regionally, North America remains the dominant market for pet veterinary supplements, driven by high pet ownership rates and a well-established veterinary healthcare infrastructure. The region's market is also supported by significant investments in research and development, resulting in innovative and high-quality products. Europe follows closely, with countries like Germany, the UK, and France showing strong demand for pet supplements. In the Asia Pacific region, rapid urbanization, rising disposable incomes, and increasing awareness about pet health are contributing to the swift market growth. Emerging economies in Latin America and the Middle East & Africa are also expected to witness considerable growth, albeit from a smaller base, due to rising pet adoption rates and improving veterinary care standards.

Product Type Analysis

The product type segment of the pet veterinary supplements market is highly diverse, catering to various health needs and conditions of pets. Joint health supplements hold a significant share within this segment, driven by the increasing incidence of arthritis and mobility issues among aging pets. These supplements often contain ingredients like glucosamine, chondroitin, and omega-3 fatty acids, which are known to support joint health and reduce inflammation. With the growing awareness of the benefits of these supplements, pet owners are increasingly incorporating them into their pets' diets, thereby boosting market growth.

Skin and coat supplements are another crucial product type, aimed at improving the overall dermatological health of pets. These supplements typically contain vitamins, minerals, and essential fatty acids that promote healthy skin and a shiny coat. The rising prevalence of skin allergies and dermatological issues among pets is driving the demand for these products. Furthermore, pet owners are becoming more conscious of their pets' appearances, leading to an increased focus on products that enhance their pets' external features. This trend is particularly prominent in urban areas where pets are often considered an extension of their owners' life

The life science products market is experiencing robust growth, driven by several key factors. The increasing prevalence of chronic diseases globally fuels demand for advanced diagnostic tools and therapeutic agents, significantly impacting the market for recombinant proteins, cell lines, and antibodies used in research and development. Furthermore, the burgeoning biopharmaceutical industry, coupled with a rise in contract research organizations (CROs) and academic research initiatives, necessitates a continuous supply of high-quality life science products. Technological advancements, including automation in laboratory processes and the development of novel assay techniques, are further enhancing efficiency and driving market expansion. While regulatory hurdles and the high cost of developing and manufacturing certain products pose some challenges, the overall market trajectory remains positive. We project a steady CAGR (let's assume a conservative 7% based on industry averages) for the next decade, reflecting sustained investment in life sciences research and the growing need for advanced tools across diverse applications, including biopharmaceutical production, diagnostics, and forensic science. The market is segmented by application (biopharmaceutical companies, CROs, academic institutions, forensic labs, food & beverage, diagnostic centers, others) and product type (recombinant proteins, cell lines, antibodies, viable tumor samples, tumor tissue microarrays, others). North America currently holds a significant market share due to its robust life sciences infrastructure and high R&D expenditure. However, Asia-Pacific is expected to witness substantial growth in the coming years, driven by rising healthcare expenditure, growing awareness of advanced diagnostics, and a burgeoning pharmaceutical industry in countries like China and India. European countries continue to contribute significantly, with strong pharmaceutical industries and robust government support for life sciences research. Competitive dynamics within the market are intense, with several established players and emerging companies vying for market share through innovation and strategic partnerships. The market's future is bright, poised for continued expansion and diversification as technology advances and the need for advanced diagnostics and therapeutics continues to grow.

Data on European cities were collected in the Urban Audit and in the Large City Audit project. The projects' ultimate goal is to contribute towards the improvement of the quality of urban life: it supports the exchange of experience among European cities; it helps to identify best practices; it facilitates benchmarking at the European level and provides information on the dynamics within the cities and with their surroundings.

At the city level, the Urban Audit contains more than 130 variables and more than 50 indicators. These indicators are derived from the variables collected by the European Statistical System.

The data is published in 20 tables within 2 main groups, plus a perception survey table:

Cities and greater cities (urb_cgc)

Population on 1 January by age groups and sex - cities and greater cities (urb_cpop1)
Population structure - cities and greater cities (urb_cpopstr)
Population by citizenship and country of birth - cities and greater cities (urb_cpopcb)
Fertility and mortality - cities and greater cities (urb_cfermor)

Living conditions - cities and greater cities (urb_clivcon)

Education - cities and greater cities (urb_ceduc)

Culture and tourism - cities and greater cities (urb_ctour)
Labour market - cities and greater cities (urb_clma)
Economy and finance - cities and greater cities (urb_cecfi)
Transport - cities and greater cities (urb_ctran)
Environment - cities and greater cities (urb_cenv)

Functional Urban Area (urb_luz)

Population on 1 January by age groups and sex - Functional Urban Area (urb_lpop1)
Population structure - Functional Urban Area (urb_lpopstr)
Population by citizenship and country of birth - Functional Urban Area (urb_lpopcb)
Fertility and mortality - Functional Urban Area (urb_lfermor)
Living conditions - Functional Urban Area (urb_llivcon)
Education - Functional Urban Area (urb_leduc)
Labour market - Functional Urban Area (urb_llma)
Transport - Functional Urban Area (urb_ltran)
Environment - Functional Urban Area (urb_lenv)
Perception survey results (urb_percep)

Data has been collected on two spatial levels in the Urban Audit:

• The City (C) according to the administrative definition, as the basic level,
• The Functional Urban Area (FUA) being an approximation of the functional urban zone centered around the city

Snapshot img

Home Healthcare Market Size 2025-2029

The home healthcare market size is forecast to increase by USD 492.7 million, at a CAGR of 15.2% between 2024 and 2029.

The market is experiencing significant growth due to the increasing preference for quality healthcare services care in the comfort of one's own home. Patient satisfaction is at an all-time high as home healthcare offers flexibility, convenience, and personalized care. However, this market faces a notable challenge that the rising incidence of life-threatening diseases necessitating home healthcare services puts immense pressure on the availability of home healthcare professionals (HCPs).
This shortage poses a significant challenge for providers, requiring innovative solutions to ensure adequate staffing and maintain the high-quality care expected by patients. Companies that can effectively address this challenge and provide reliable, high-quality medical devices and home healthcare services will be well-positioned to capitalize on the market's potential for growth.

What will be the Size of the Home Healthcare Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market continues to evolve, shaped by various sectors and dynamic market activities. Registered nurses (RNs) and other healthcare professionals, including pediatric care specialists, occupational therapists, and home healthcare agencies, deliver personalized care to patients in need. This care encompasses a range of services, from companion care and wound care to rehabilitation therapy and hospice care. Home healthcare software and patient portals facilitate efficient care coordination and medication management, ensuring HIPAA compliance. The aging population's increasing demand for in-home care necessitates continuous workforce development through employee training and quality improvement initiatives. Cost-effective solutions, such as homemaker services and telehealth services, address the chronic disease epidemic and hospital readmissions.

Value-based care and patient satisfaction are key drivers, with healthcare outcomes and diabetes management being crucial focus areas. Assistive devices, including mobility aids and oxygen therapy, enhance the quality of life for patients, while remote patient monitoring and in-home care provide essential support for those with complex conditions. Home infusion therapy and skilled nursing care ensure comprehensive care for patients with chronic diseases. The market's ethical considerations and regulatory landscape continue to unfold, with ongoing compliance regulations and Data Security measures ensuring the highest standards of care. Private insurance coverage and care coordination further strengthen the industry's foundation, enabling it to adapt and thrive in the ever-changing healthcare landscape.

How is this Home Healthcare Industry segmented?

The home healthcare industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Products
  Services
  Solutions


Application

  Medical treatment
  Preventive healthcare


Age Group

  Adults
  Geriatric
  Pediatric


Disease Type

  Cardiovascular disorder and hypertension
  Diabetes and kidney disorders
  Cancer
  Wound care
  Others


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Russia
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW). 

By Type Insights

The products segment is estimated to witness significant growth during the forecast period.

The market encompasses a range of services and products, including Speech-Language Pathologists, Medical Supplies, Home Care Franchises, Mental Health Services, Medical Social Workers, and HIPAA Compliance. Post-Hospital Care, Personalized Care, and Home Healthcare Cost-Effectiveness are key drivers in the market. Ethical Considerations, Palliative Care, and Chronic Disease Epidemic require ongoing Quality Improvement to address Hospital Readmissions and Chronic Disease Management. Value-Based Care prioritizes Patient Satisfaction and Healthcare Outcomes, with Diabetes Management a significant focus. Home Healthcare Agencies employ various professionals such as Homemaker Services, Physical Therapists, Oxygen Therapy Providers, Home Health Aides, Personal Care Services, Telehealth Services, and Home Infusion Therapy specialists.

Compliance Regulations necessitate Patient Portals and Registered Nurses (RNs) for care coordination. Pediatric Care, Occupational Therapists, Companion Care, Wound Care, and Geriatric Care cater to diverse patient needs. The Home Healthcare Workforce r

BackgroundParkinson’s disease (PD) significantly reduces quality of life (QoL), particularly due to its complex interplay of motor and nonmotor symptoms. While personality traits influence QoL in chronic diseases, their longitudinal effects in people with PD (PwPD) remain underexplored. This study evaluates the longitudinal predictive influence of neuroticism, conscientiousness, and openness on QoL in PwPD over two waves of the Survey of Health, Aging, and Retirement in Europe (SHARE).MethodsThis study utilized longitudinal data from 100 PwPD participants in waves 7 and 8 of the Survey of Health, Aging, and Retirement in Europe (SHARE). QoL was assessed using the CASP-12 scale, while personality traits were measured with the Big Five Inventory (BFI-10). Linear regressions and generalized estimating equations (GEE) were used to examine cross-sectional and longitudinal associations between personality traits and QoL, controlling for sociodemographic, psychosocial, and health-related variables.ResultsNeuroticism was consistently associated with lower QoL across all analyses. Cross-sectional results showed neuroticism as the strongest predictor of QoL decline in wave 7 (beta = -0.33, p 

Chronic Traumatic Encephalopathy Patient Support Market Outlook

The global Chronic Traumatic Encephalopathy (CTE) patient support market is projected to witness significant growth, with a robust CAGR anticipated over the forecast period from 2024 to 2032. This growth can be attributed to increasing awareness of CTE, advances in diagnostic techniques, and a growing emphasis on mental health and neurological well-being.

One of the primary growth factors for the CTE patient support market is the rising incidence of CTE, particularly among athletes and individuals in high-contact professions. As research continues to link repeated head injuries to the development of CTE, the demand for specialized support services is expected to increase. Sports organizations, in particular, are becoming more proactive in addressing the long-term health of their players, leading to higher investment in preventive and supportive measures. This shift is not only seen in professional sports but also in amateur and youth leagues, where awareness campaigns are driving policy changes and support infrastructure development.

Another crucial factor contributing to market growth is the advancement in diagnostic technologies. Earlier detection of CTE through improved imaging techniques and biomarker research is allowing for timely intervention and management. Early diagnosis can significantly enhance the quality of life for patients by providing them with access to necessary support services before the disease progresses. As these technologies become more accessible and affordable, we can expect a broader adoption, further propelling market growth.

The increasing societal focus on mental health and neurological disorders is also playing a vital role in the expansion of the CTE patient support market. Governments and healthcare organizations are channeling resources towards the development of comprehensive support systems for neurological conditions, which includes CTE. Public health campaigns and educational programs are raising awareness about the importance of mental health, encouraging individuals to seek support services earlier. This cultural shift is expected to drive demand for various support services, ranging from counseling to rehabilitation.

From a regional perspective, North America is likely to continue dominating the CTE patient support market due to its advanced healthcare infrastructure and high awareness levels. However, other regions like Europe and Asia Pacific are also showing substantial growth potential. Europe is benefiting from strong healthcare policies and increasing research activities, while Asia Pacific is witnessing growing investments in healthcare infrastructure and rising public awareness. These regional dynamics are expected to shape the market landscape significantly over the next decade.

Service Type Analysis

The service type segment of the CTE patient support market encompasses various forms of support, including counseling services, rehabilitation services, support groups, educational programs, and others. Counseling services are anticipated to hold a significant share of the market. The rising need for mental health support among CTE patients, who often experience cognitive and emotional challenges, is driving this segment. Counseling services provide patients with psychological support and coping strategies, which are crucial for managing the long-term effects of CTE.

Rehabilitation services are another critical component of the CTE patient support market. These services aim to help patients regain function and improve their quality of life through physical, occupational, and speech therapy. As the understanding of CTE's impact on motor and cognitive functions deepens, the demand for comprehensive rehabilitation programs is expected to grow. These programs are often tailored to the individual needs of patients, making them a vital part of the support ecosystem.

Support groups play a pivotal role in the CTE patient support market by providing a platform for patients and their families to share experiences, receive emotional support, and gain valuable insights into managing the condition. The communal aspect of support groups helps reduce feelings of isolation and provides a sense of belonging, which can be particularly beneficial in dealing with the emotional and psychological aspects of CTE.

Educational programs are essential for raising awareness and providing information about CTE. These programs target not only patients and their families but also healthcare profess